Researchers from ChristianaCare’s Helen F. Graham Cancer Center & Research Institute and the University of Delaware have uncovered what may be a fundamental set of rules that keep human tissue organized, even as the body replaces billions of cells every day. In a recent study published in the scientific journal Biology of the Cell, researchers demonstrate how five simple rules …
ChristianaCare’s Helen F. Graham Cancer Center & Research Institute has become the first facility in Delaware to offer CARVYKTI, a chimeric antigen receptor (CAR) T-cell therapy for adults with relapsed or treatment-resistant multiple myeloma, a rare but serious form of blood cancer. “CAR-T cell therapy represents a paradigm shift in the treatment of multiple myeloma,” said Dr. Thomas Schwaab, Bank …
WILMINGTON- A new study published in Nature Medicine suggests that metastatic cancer patients who regularly report their symptoms through a home-based electronic monitoring system experience improved quality of life, better clinical outcomes, and fewer emergency department visits compared to those who do not participate in such reporting. The study, led by researchers from ChristianaCare’s Helen F. Graham Cancer Center & …
